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employed a pragmatic literature, industry, and US payer policy review to determine
instances of HEOR datasets tangibly impacting US payer formulary coverage, or
having limited impact, supplemented by prior CBPartners HEOR-focused US payer
primary research. Additionally, an online survey was conducted with a curated list of
n=15 US payers across MCO, IDN, and PBM organizations to provide further context
surrounding recent examples of manufacturer HEOR data materially influencing
decisions at P&T, different ways HEOR data can subsequently change formulary
coverage, and the extent to which “HEOR class effects” may negatively impact late-
to-market competitors within crowded therapeutic classes. Results: In one instance
of HEOR data positively impacting formulary coverage, tiotropium bromide’s phar-
maco-economic model linked its exacerbations data to downstream savings, which
ultimately influenced some payers to prefer it in the COPD setting. However, other
examples exist of HEOR data failing to move the needle for payers to substantially
improve access or policy, such as PCSK-9 outcomes data subsequent HEOR impact.
Additionally, as other therapy areas (i.e. moderate-severe asthma; diabetes; etc.)
become more crowded and manufacturers seek further differentiation for their
products, “HEOR class effects” may become more prevalent, whereby one product’s
HEOR analyses negatively impacts future competitors by resetting the standards for
payer data requirements. Conclusions: US payer organizations employ different
philosophies towards incorporating HEOR analysis into changes (positive or nega-
tive) in formulary and access decisions, highlighting the benefit in studying evolving
payer interpretations of manufacturer HEOR analyses to help reconcile underlying
rationale shaping value perceptions.
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Objectives: Childhood mental illness (MI) has been steadily increasing in the U.S. The
development of MI can be impacted by a number of social determinants including
peer-group, familial, community, and income-based factors, in addition to comor-
bidity. This study investigated the rate of MI in a sample of U.S. youths to examine
the relationship between socioeconomic status and MI. Methods: This retrospective
analysis utilized the IBM® MarketScan® Research Databases spanning 2012-2018.
Annual samples of youths aged 4-17 continuously enrolled for the stated year and
year prior were defined in the Commercial and Medicaid databases; prevalence rates
of MI were calculated. Children with a diagnosis code for alcohol/substance abuse,
depression, anxiety, eating disorders, bipolar, schizophrenia, developmental disor-
ders, or attention/conduct disorders were classified as having a MI; rates were
compared between commercially insured and Medicaid youths. Results: From 2013
to 2018, prevalence rates of mental illness were consistently higher for Medicaid
compared to commercially insured youths; the gap in diagnosis decreased from
92.9% in 2013 (22.3% vs. 11.6%) to 44.2% in 2018 (20.8% vs. 14.4%). Among commer-
cially insured youths, the prevalence rate of any MI increased 24.7%, while Medicaid
youths evidenced a slight decrease (-5.5%). For specific diagnoses, rates of anxiety
increased 38.5% and 67.9% for Medicaid and commercial groups respectively, while
substance abuse rates declined for both (-41.0% vs. -20.4%). Depression, attention/
conduct, and developmental disorders were elevated and stable over time in
Medicaid youths, while commercial youths evidenced increases. Con-
clusions: Medicaid coverage was associated with an increased likelihood of MI in
youths, though rates are increasing among the commercially insured. Although in-
come level and disability continue to be associated with severe MI, the increased
rates of MIs among the commercially insured suggest a number of non-material
determinants are also significant factors in the mental well-being of US youths, and
warrant further investigation.
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Objectives: Meals prepared away from the home have been associated with worse
diet quality and higher food expenditures. We examined these relationships ac-
counting for county-level cost per meal, as the price of food affects consumer
behavior and has not been previously studied. Methods: Data from the 2011-2014
National Health and Nutrition Examination Survey (NHANES) of participants living in
urban areas, 2015 Map the Meal Gap county-level food price, and 2017 U.S.
Department of Agriculture (USDA) Food Atlas were compiled for analysis. We used
multilevel, random effects ordered logistic and linear regression modeling to study
associations between the frequency of consumption of meals prepared away from
the home, diet quality and food expenditures, controlling for the county-level cost
per meal, county-level density of food establishments, and county- and individual-
level sociodemographic characteristics. Results: 38.7% of our study sample
consumed meals prepared away from the home frequently (5-21 meals/week), 24.6%
sometimes (2-4 meals/week), and 26.7% never/rarely (0-1 meals/week). Greater
frequency of consuming meals prepared away from the home was associated with
worse diet measures (frequent consumers ate 174.8 more calories per day and 343.0
more grams of sodium per day relative to never/rarely consumers, both p,0.05) and
higher total food expenditures (frequent consumers spent $168.55 more per month
relative to the never/rarely consumers) when controlling for cost per meal and other
county-level factors. The highest tertile of county-level cost per meal was associated
with a 3% decrease in food expenditures allocated to meals prepared away from the
home, relative to counties with the lowest tertile cost per meal (b=-0.03; p,0.05).
Conclusions: Higher cost per meal reduced the amount of spending on meals pre-
pared away from the home. An excise tax to increase the price of unhealthy meals
prepared away from the home may decrease the consumption of meals prepared
away from the home.
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Objectives: An ICD-10 coding adaptation of the Charlson comorbidity index (CCI) has
not yet been validated for predicting one-year mortality in US healthcare data. We
validated a previously developed coding adaptation in US administrative claims and
compared its performance with the Canadian adaptation (Quan et al. Med Care
2005;43:1130-9) currently used in some US healthcare studies. Methods: Cohorts of
patients with diverse medical conditions (rheumatoid arthritis, hip/knee replace-
ment, lumbar spine surgery, AMI, stroke, pneumonia) in the IBM MarketScan
Research Databases (a US commercial claims data source) were linked with the IBM
MarketScan Mortality file. Predictive ability of both the US and Canadian coding
adaptations of the CCI was measured using c-statistics, after adjusting for age and
sex, and compared by the method of DeLong and colleagues (Biometrics;
1988;44:837-45). Full code lists are available at https://doi.org/10.5281/zenodo.36
04394. Results: C-statistics were generally high (w0.8 or greater) for five of seven
patient cohorts. Results were similar between the US and Canadian adaptations, with
absolute differences ,0.001. For lumbar spine surgery, CCI contributed a more
substantial role in predicting 12-month mortality than for other conditions. For hip/
knee replacement and pneumonia, age and sex played a more substantial role, while
for AMI and stroke, other factors were likely more important (e.g., distribution of
vascular disease, severity, health delivery factors, etc) although age, sex, and CCI play
some role for predicting mortality. Conclusions: This US ICD-10 coding adaptation of
the CCI performed well in US commercial claims for predicting one-year mortality
and similarly to the Canadian adaptation. Using the Canadian adaptation had mini-
mal impact on predictive ability but could result in erroneous assignment of
comorbidities (i.e., construct validity). We recommend using adaptations specific to
the country of origin of the data based on good research practice.
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Objectives: to establish the prevalence and associated factors to suicide attempts
(SA) in low-income adolescents from the Caribbean region of Colombia Methods: A
cross sectional study was conducted. Adolescents between 10-24 years of age resi-
dents in 21 municipalities in the Caribbean region of Colombia were randomly
selected from the population affiliated to a subsidized-regime insurance company
between 2014-2018. A previously constructed questionnaire was used to obtain in-
formation regarding sociodemographic variables and potential risk factors. A self-
reported antecedent of suicide attempt was defined as a case. Bivariate and multi-
variate logistic regression models were used to establish associated factors. Absolute
and relative frequencies were reported. Relative frequencies were compared with the
Chi2 test and continuous variables were compared with the t-test. A p value ,0.050
was considered significant Results: A total of 35,214 adolescents with a mean (SD)
age of 16.0 (4.1) years were included. Of these, 55.7% were women and 63.9% lived in
urban areas. Prevalence of SA was 2.6% (95% IC 2.4-2.8). Patients with SA had a mean
of 17.2 (3.7) years of age and were 1.2 years older compared to patients with no
attempts (t-test: p,0.05). A higher prevalence was found in women compared to
men (3.5% vs 1.5%) (p,0.001). The highest prevalence was found in the 15-19 age
group (10-14yr: 1.8%; 15-19yr: 3.3%; 20-24yr: 2.9%). Risk factors (OR 95% IC) for SA
were age over 14 years (15-19=OR 1.6; 1.3-1.9), constant physical violence by parents
(OR 3.5; 1.8-6.5), previous visit to physiologist (OR 1.7; 1.5-2.1), feeling sad/empty
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most of the time (OR 6.6; 5.6-8.0) and a previous substance use (OR 4.8; 3.5-6.6).
Conclusions: suicide is an important cause of burden in the young population.
Mental health promotion with a focus in the social determinants of health should be
public health priority in this population.
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Objectives: Efforts to curtail the over-prescription of opioids in the US have included
legislation to enhance prescription drug monitoring programs and regulation of pain
clinics, along with an increase in physician training programs focused on improved
prescribing practices. The purpose of this study was to examine real world evidence
of opioid prescribing trends over the past decade among newly diagnosed chronic
pain (CP) patients. Methods: This retrospective analysis utilized the IBM® Market-
Scan® Research Database spanning 2012-2017. Annual samples of adults with
continuous enrollment for two years (the index year and prior year) were identified.
All patients were required to present two medical claims with a diagnosis for low
back pain, osteoarthritis, fibromyalgia, diabetic peripheral neuropathy, or chronic
pain during the index year, and must have presented an absence of pain diagnoses
and opioid prescriptions during the preceding year. Opioid and non-opioid analgesic
use and total healthcare expenditure was assessed. Results: From 2012 to 2017, there
was a 17.2% decrease in the proportion of CP patients prescribed opioids (40.6% to
33.6%). The mean days’ supply of opioids per prescription decreased (-13.0%; 8.85
days to 7.70 days), as did the total number of opioid fills (-17.4%; 2.5962.82 to
2.1462.20), and total days’ supply (-25.3%; 27.9649.5 to 20.8640.7). There was a
slight increase in the prescription of non-opioid analgesics over the study period
(6.1%; 40.2% to 42.6%), and a 37.1% decrease in the proportion of patients with annual
supplies of opioids . 90 days (7.1% to 4.4%). Total healthcare costs increased 8.4%
($15,3046$34,950 to $16,3336$41,599). Conclusions: Opioid prescriptions have
been decreasing over the past decade among CP patients. This trend included a
decline in extended use (. 90 days), and did not result in notable increases in
healthcare costs. Though work is still needed, results demonstrate measurable
progress in the ongoing opioid epidemic.
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Objectives: Atopic disease is associated with chronic inflammation, and anemia has
been reported in patients with inflammatory disorders such as rheumatoid arthritis,
chronic obstructivepulmonarydisease, and irritablebowel disease. Theobjectiveof this
study was to determine whether atopic disease is associated with an increased risk of
anemia. Methods: A cross-sectional study with propensity score weighting was
conducted using a health insurance review agency claims dataset comprised of ran-
domized patients who used the Korean national health system at least once in 2016.
The association between atopic disease (asthma, atopic dermatitis, allergic rhinitis)
and anemia (iron deficiency anemia [IDA] and/or anemia of inflammation [AI]) was
examined. Results: A total of 1,468,033 patients were included in this study. The IDA/
AI prevalence was 3.1% (45,681 patients). After propensity score weighting, therewere
46,958 and 45,681 patients in the non-anemic and anemic groups, respectively. The
prevalence of IDA/AI in patients with atopic dermatitis, allergic rhinitis, or asthma had
an odds ratio (OR) of 1.40 (95% confidence interval [CI], 1.33–1.48; P , .001), 1.17 (95%
CI, 1.14–1.21; P, .001), and 1.32 (95% CI, 1.28–1.36; P, .001), respectively. In addition,
the prevalence of IDA increased with higher numbers of atopic diseases. Con-
clusions: The prevalence of IDA/AI was higher in patients with atopic disease, even
after adjusting for demographic characteristics and other risk factors. Further study is
needed to distinguish between IDA and AI and to enhance understanding of the
etiology of anemia in patients with inflammatory conditions.
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Objectives: Asian Americans are the fastest-growing minority group in the United
States, yet little is known about their multimorbidity. This study examined the asso-
ciation of Asian Indians, Chinese and non-HispanicWhites (NHWs) tomultimorbidity.
Methods: We utilized a cross-sectional design with data from the National Health
Interview Survey pooled sample (2012–2017) of Asian Indians, Chinese and NHWs (N
= 132,666). Multimorbidity was defined as the presence of two or more selected
chronic conditions. Unadjusted and adjusted logistic regressions were used to
examine the independent relationship of race/ethnicity to multimorbidity.
Results: Our study sample represented 1.9% Asian Indians, 1.8% Chinese and 96.3%
NHWs. Significant differences in socio-economic and lifestyle factors were noted
between the three groups. Asian Indians had the highest percentage of college ed-
ucation (73%), followed by Chinese (56.1%) and NHWs (34.4%). Asian Indians were
less likely to be current smokers, have physical inactivity and more likely to be obese
compared to NHWs. In unadjusted analyses (p , .001), 17.1% Asian Indians, 17.9%
Chinese, and 39.0% NHWs had multimorbidity. Among the dyads, high cholesterol
and hypertension were the most common combination among Asian Indians (32.4%),
Chinese (41.0%) and NHWs (20.6%). After adjusting for age, sex, and other risk factors,
Asian Indians (AOR=0.47, 95% CI=[0.40, 0.56]) and Chinese ([AOR=0.44, 95% CI=[0.38,
0.51]) were less likely to have multimorbidity compared to NHWs. Age stratified (,
65 years and $ 65 years) analyses revealed similar findings. Conclusions: Asian
Indians and Chinese were associated with a lower prevalence of multimorbidity
compared to NHWs after controlling for age, sex, and other risk factors. Although
overall multimorbidity rates were lower, Asian Indians and Chinese were more likely
to have high-cholesterol and hypertension, risk factors to heart disease and diabetes.
Further research on type of multimorbidity, specifically those related to cardiovas-
cular clusters in Asian Indians and Chinese is needed.
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Objectives: SRH is a measure of general health status and if often used as a predictive
measure of health outcomes. The research aim was to study factors such as de-
mographic and socioeconomic determinants, noncommunicable chronic diseases
(NCD) and functional capacity on self-rated health, and to verify the association with
health plan utilization and costs. Methods: Observational study of 2,188 benefi-
ciaries of a health plan in Brazil who answered online epidemiological profile.
Dependent variable, SRH dichotomized into good (excellent, very good, and good
categories) or poor self-rated health (regular and poor). Independent variables: de-
mographic, socioeconomic, presence/absence of NCD, stroke and chronic pain. Sta-
tistical: association between SRH and each variable, multiple binary logistic
regression. Results presented as odds ratios and prevalence ratios, 95% confidence
intervals, significance when p,0.05. Results: Chance of self-rated health as poor was
2.1 times higher in elderly, men 11.8%, unmarried people (47.9%), low-income fam-
ilies (87.8%), low education level (59.2%) and 3.9 times higher in patients with at least
one NCD and 4.8 times when more than one. Increased chance of a negative
perception: stroke (4.3 times), chronic pain (3.6 times), diabetes mellitus (3.3 times),
arterial hypertension (2.6 times) and COPD (1.8 times). Annual HC utilization rate by
beneficiaries with negative SRH were higher for all procedures: visits, tests, therapies
and hospitalizations (38.5%, 44.5%, 38.1% and 134.6%, respectively) with additional
annual assistance expenses per capita of 80.5% (BRL 9,805 versus BRL 5,432). Con-
clusions: Self-rated health is a subjective indicator of general health. Individuals in
rating their health may consider a variety of factors, some of which may not be
apparent to health providers. HC utilization is higher by negative SRH group. Some of
the studied variables could be changed with programs and those should be imple-
mented to better quality of life and improves a resource management.
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Objectives: Psychotropic polypharmacy has been increasing in the U.S. despite a lack
of evidence on safety and effectiveness. Though antidepressants and other psycho-
tropics carry increased safety concerns in pediatric patients, the prevalence of psy-
chotropic polypharmacy among children, adolescents, and young adults treated with
antidepressants is unknown. This study will characterize the prevalence of psycho-
tropic polypharmacy among children (ages 6-12), adolescents (ages 13-18), and
young adults (ages 19-26) treated with antidepressants in the U.S. Methods: A na-
tionally representative sample of individuals aged 6-25 years dispensed at least one
antidepressant in 2016 was extracted using the IQVIA LRx longitudinal database.
Concomitant psychotropic use was compared overall, and by age and gender. Psy-
chotropic polypharmacy was defined as the use of two or more psychotropic med-
ications with overlapping days’ supply. Psychotropic therapeutic classes include
antipsychotics, antianxiety, benzodiazepines, CNS stimulants, and antidepressant
subclasses. Results: Nearly half (48.6% [48.4-48.8%]) of young antidepressant users
in the U.S. concurrently use two or more psychotropic medications. Boys treated with
antidepressants have a 1.2-fold higher prevalence of psychotropic polypharmacy
(54.0% [53.7-54.3%]) compared to girls (45.4% [45.2-45.7%]). Children have the
highest prevalence of psychotropic polypharmacy (51.7% [51.2-52.3%]), followed by
adolescents (49.8% [49.4-50.1%]), and young adults (47.3% [47.0-47.5%]). There were
also notable age and gender difference in the types of psychotropic combinations.
The most common combination was CNS stimulants-SSRIs are the most common
pair in children (boys: 51.2% [50.2-52.1%], girls: 44.2% [42.9-45.5%]) and adolescent
boys (20.3% [19.8-20.8%]). Atypical antidepressants-SSRIs are also highly prevalent in
adolescent girls (22.2% [21.7-22.8%]). Antipsychotic-SSRIs are also common (.20%)
across all ages. Conclusions: Psychotropic polypharmacy affects more than half of
children, adolescents, and young adults treated with antidepressants in the U.S. The
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